Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CSTL
#2185
Castle Biosciences, Inc. Common Stock
29.570
0
-3.05%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-3.05%
Monthly Change
-30.88%
6 month change
+20.13%
Year Change
+20.13%
Previous Close
30.500
0
Open
29.570
0
Bid
Ask
Low
29.570
0
High
29.570
0
Volume
98
Markets
US Stock Market
Healthcare
CSTL
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
24.98 M
25.41 M
26.58 M
27.45 M
28.51 M
29.73 M
—
Valuation ratios
Enterprise value
1.27 B
759.72 M
482.49 M
504 M
640.2 M
1.04 B
2.62 B
Price to earnings ratio
-124.35
-34.57
-8.83
-10.26
42.98
-46.87
-261.18
Price to sales ratio
20.29
11.45
4.33
2.68
2.35
—
—
Price to cash flow ratio
128.85
56.77
14.25
104.62
12.02
17.52
46.71
Price to book ratio
3.06
2.62
1.49
1.5
1.71
2.39
3.41
Enterprise value to EBITDA ratio
-178.18
-20.69
-5.97
-9.04
26.04
—
—
Profitability ratios
Return on assets %
0.02
0.07
0.15
0.13
0.03
0.04
0.05
Return on equity %
0.02
0.08
0.17
0.15
0.04
0.05
0.06
Return on invested capital %
214.6
318.99
226.88
171.67
17.63
79.98
90.61
Gross margin %
84.54
83.18
76.64
79.53
81.87
79.38
317.36
Operating margin %
10.44
42.6
53.16
30.93
2.61
12.44
49.26
EBITDA margin %
-11.35
-39.03
-58.93
-25.38
7.4
-0.63
-40.01
Net margin %
16.42
33.26
48.99
26.15
5.49
7.02
27.51
Liquidity ratios
Quick ratio
20.47
14.13
7.98
6.04
7.13
5.11
27.29
Current ratio
20.58
14.21
8.09
6.2
7.29
5.26
27.95
Inventory turnover
5.61
7.47
—
—
—
—
—
Asset turnover
0.22
0.21
0.3
0.49
0.67
0.62
0.64
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
0.02
0.02
0.07
Long term debt to total equity ratio
0
—
—
—
0.02
0.02
0.08
Per share metrics
Operating cash flow per share
0.52
0.76
1.6
0.21
2.22
2.22
2.21
EBIT per share
-0.45
-1.6
-3.5
-2.54
0.29
-1.48
-2.61
EBITDA per share
-0.38
-1.46
-3.1
-2.08
0.84
-0.08
-1.19
Total debt per share
—
—
—
—
—
—
—
Cash per share
21.65
13.11
9.93
9.07
15.95
16.64
65.28
Net current asset value per share
22.7
14.07
11.22
11.03
12.31
12.46
48.77
Tangible book value per share
21.96
12.84
10.47
10.22
11.95
12.81
49.93
Working capital per share
21.59
13.08
9.83
9.25
10.62
10.09
41.47
Book value per share
21.96
16.38
15.32
14.6
15.58
16.24
63.11
News
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus
PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View
Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline
Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down
Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway
Castle Biosciences, Inc. (CSTL) Q4 2025 Earnings Call Transcript
Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Beats Revenue Estimates
Castle Biosciences Q4 2025 slides: test volumes surge 42%, enters AD market
Viatris Q4 EPS Tops, Brands Drive Revenue Growth, Stock Up
Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change